Clinical Trial Update: Dose Response Study of Inhaled Ciclesonide (Glucocorticosteroid) to Patients With Persistent Asthma [Phase 2]

View source ↗

Summary

This document notes the completion of a Phase 2 dose-response trial evaluating inhaled ciclesonide for persistent asthma. It confirms the study status as comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• ciclesonide (ciclesonide)

Snippet

Sponsor: Sanofi | Conditions: Asthma | Phase 2 | Status: COMPLETED